A citation-based method for searching scientific literature

Jon Zugazagoitia, Pedro Pérez-Segura, Arancha Manzano, Ignacio Blanco, Ana Vega, Ana Custodio, Alex Teulé, Laura Fachal, Beatriz Martínez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, Isabel Chirivella, Vicente Garcés, Pilar Garre, Atocha Romero, Trinidad Caldés, Eduardo Díaz-Rubio, Miguel de la Hoya. Breast Cancer Res Treat 2014
Times Cited: 12







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
360
41

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
41

Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC).
R Andrés, I Pajares, J Balmaña, G Llort, T Ramón Y Cajal, I Chirivella, E Aguirre, L Robles, E Lastra, P Pérez-Segura,[...]. Clin Transl Oncol 2014
20
41

Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer.
Michelle W Wong-Brown, Cliff J Meldrum, Jane E Carpenter, Christine L Clarke, Steven A Narod, Anna Jakubowska, Helena Rudnicka, Jan Lubinski, Rodney J Scott. Breast Cancer Res Treat 2015
66
33

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years.
L Robertson, H Hanson, S Seal, M Warren-Perry, D Hughes, I Howell, C Turnbull, R Houlston, S Shanley, S Butler,[...]. Br J Cancer 2012
67
25

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.
Priyanka Sharma, Jennifer R Klemp, Bruce F Kimler, Jonathan D Mahnken, Larry J Geier, Qamar J Khan, Manana Elia, Carol S Connor, Marilee K McGinness, Joshua M W Mammen,[...]. Breast Cancer Res Treat 2014
93
25

Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho. N Engl J Med 2010
25

Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.
Bruce G Haffty, Qifeng Yang, Michael Reiss, Thomas Kearney, Susan A Higgins, Joanne Weidhaas, Lyndsay Harris, Willam Hait, Deborah Toppmeyer. J Clin Oncol 2006
743
25

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
25

Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia.
Grazia Palomba, Mario Budroni, Nina Olmeo, Francesco Atzori, Maria Teresa Ionta, Marina Pisano, Francesco Tanda, Antonio Cossu, Giuseppe Palmieri. Oncol Lett 2014
8
37



Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation.
Jae Myoung Noh, Boo-Kyung Han, Doo Ho Choi, Sun Jung Rhee, Eun Yoon Cho, Seung Jae Huh, Won Park, Hyojung Park, Seok Jin Nam, Jeong Eon Lee,[...]. J Breast Cancer 2013
15
25

Familial breast cancer.
F Lalloo, D G Evans. Clin Genet 2012
96
16


Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
16

Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.
Anne-Renee Hartman, Rajesh R Kaldate, Lisa M Sailer, Lisa Painter, Charles E Grier, Robbin R Endsley, Marlena Griffin, Stephanie A Hamilton, Cynthia A Frye, Mark A Silberman,[...]. Cancer 2012
120
16

Limited family structure and BRCA gene mutation status in single cases of breast cancer.
Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
130
16

Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.
Alfons Meindl, Nina Ditsch, Karin Kast, Kerstin Rhiem, Rita K Schmutzler. Dtsch Arztebl Int 2011
75
16

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.
S R Young, Robert T Pilarski, Talia Donenberg, Charles Shapiro, Lyn S Hammond, Judith Miller, Karen A Brooks, Stephanie Cohen, Beverly Tenenholz, Damini Desai,[...]. BMC Cancer 2009
167
16

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.
Aleix Prat, Barbara Adamo, Maggie C U Cheang, Carey K Anders, Lisa A Carey, Charles M Perou. Oncologist 2013
312
16

Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.
Seth Rummel, Erika Varner, Craig D Shriver, Rachel E Ellsworth. Breast Cancer Res Treat 2013
35
16

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
William D Foulkes, Ingunn M Stefansson, Pierre O Chappuis, Louis R Bégin, John R Goffin, Nora Wong, Michel Trudel, Lars A Akslen. J Natl Cancer Inst 2003
694
16

SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
G Llort, I Chirivella, R Morales, R Serrano, A Beatriz Sanchez, A Teulé, E Lastra, J Brunet, J Balmaña, B Graña. Clin Transl Oncol 2015
46
16

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
16

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Daniel P Silver, Andrea L Richardson, Aron C Eklund, Zhigang C Wang, Zoltan Szallasi, Qiyuan Li, Nicolai Juul, Chee-Onn Leong, Diana Calogrias, Ayodele Buraimoh,[...]. J Clin Oncol 2010
643
16

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
Gunter von Minckwitz, Andreas Schneeweiss, Sibylle Loibl, Christoph Salat, Carsten Denkert, Mahdi Rezai, Jens U Blohmer, Christian Jackisch, Stefan Paepke, Bernd Gerber,[...]. Lancet Oncol 2014
472
16

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
340
16

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
16

Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Roman Rouzier, Charles M Perou, W Fraser Symmans, Nuhad Ibrahim, Massimo Cristofanilli, Keith Anderson, Kenneth R Hess, James Stec, Mark Ayers, Peter Wagner,[...]. Clin Cancer Res 2005
16

Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.
Banu Arun, Soley Bayraktar, Diane D Liu, Angelica M Gutierrez Barrera, Deann Atchley, Lajos Pusztai, Jennifer Keating Litton, Vicente Valero, Funda Meric-Bernstam, Gabriel N Hortobagyi,[...]. J Clin Oncol 2011
104
16

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
William M Sikov, Donald A Berry, Charles M Perou, Baljit Singh, Constance T Cirrincione, Sara M Tolaney, Charles S Kuzma, Timothy J Pluard, George Somlo, Elisa R Port,[...]. J Clin Oncol 2015
461
16

Cancer statistics, 2014.
Rebecca Siegel, Jiemin Ma, Zhaohui Zou, Ahmedin Jemal. CA Cancer J Clin 2014
16

High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
Gaëlle Judes, Khaldoun Rifaï, Marine Daures, Lucas Dubois, Yves-Jean Bignon, Frédérique Penault-Llorca, Dominique Bernard-Gallon. Cancer Lett 2016
18
16

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
Rita Nanda, Laura Q M Chow, E Claire Dees, Raanan Berger, Shilpa Gupta, Ravit Geva, Lajos Pusztai, Kumudu Pathiraja, Gursel Aktan, Jonathan D Cheng,[...]. J Clin Oncol 2016
742
16

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
244
16

The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Sohrab P Shah, Andrew Roth, Rodrigo Goya, Arusha Oloumi, Gavin Ha, Yongjun Zhao, Gulisa Turashvili, Jiarui Ding, Kane Tse, Gholamreza Haffari,[...]. Nature 2012
16

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Antonino Musolino, Maria A Bella, Beatrice Bortesi, Maria Michiara, Nadia Naldi, Paola Zanelli, Marzia Capelletti, Debora Pezzuolo, Roberta Camisa, Mario Savi,[...]. Breast 2007
84
16

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Deann P Atchley, Constance T Albarracin, Adriana Lopez, Vicente Valero, Christopher I Amos, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, Banu K Arun. J Clin Oncol 2008
344
16

Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer.
Judy C Boughey, Tanya L Hoskin, Amy C Degnim, Thomas A Sellers, Joanne L Johnson, Melanie J Kasner, Lynn C Hartmann, Marlene H Frost. Ann Surg Oncol 2010
90
16

Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort.
Rachel Greenup, Adam Buchanan, Wendy Lorizio, Keelia Rhoads, Salina Chan, Tracey Leedom, Robin King, Jane McLennan, Beth Crawford, P Kelly Marcom,[...]. Ann Surg Oncol 2013
120
16

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Camilo Adem, Carol Reynolds, Cheryl L Soderberg, Jeffrey M Slezak, Shannon K McDonnell, Thomas J Sebo, Daniel J Schaid, Jeffrey L Myers, Thomas A Sellers, Lynn C Hartmann,[...]. Cancer 2003
56
16

The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
C Villarreal-Garza, J N Weitzel, M Llacuachaqui, E Sifuentes, M C Magallanes-Hoyos, L Gallardo, R M Alvarez-Gómez, J Herzog, D Castillo, R Royer,[...]. Breast Cancer Res Treat 2015
43
16


Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.
Alexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, Rob A E M Tollenaar, Flora E van Leeuwen. PLoS One 2015
50
16

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
16

Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women.
Traci N Bethea, Lynn Rosenberg, Nelsy Castro-Webb, Kathryn L Lunetta, Lara E Sucheston-Campbell, Edward A Ruiz-Narváez, Marjory Charlot, Song-Yi Park, Elisa V Bandera, Melissa A Troester,[...]. Cancer Epidemiol Biomarkers Prev 2016
13
16

Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.
Abenaa M Brewster, Mariana Chavez-MacGregor, Powel Brown. Lancet Oncol 2014
119
16

Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database.
Gloria J Morris, Sashi Naidu, Allan K Topham, Fran Guiles, Yihuan Xu, Peter McCue, Gordon F Schwartz, Pauline K Park, Anne L Rosenberg, Kristin Brill,[...]. Cancer 2007
336
16

Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis.
Eun-Ha Lee, Sue K Park, Boyoung Park, Sung-Won Kim, Min Hyuk Lee, Sei Hyun Ahn, Byung Ho Son, Keun-Young Yoo, Daehee Kang. Breast Cancer Res Treat 2010
57
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.